Description: Myomo, Inc. is a commercial stage medical robotics Company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Based on patented technology developed at MIT and the Company, Myomo develops and markets the MyoPro® product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve injury such as brachial plexus injury, or other neuromuscular disability such as amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). It is provided through clinical relationships with VA medical centers, leading rehabilitation hospitals, and Orthotics and Prosthetics (“O&P”) practices. Several hundred have been successfully used by patients. It is the only device that, sensing a patient’s own neurological signals through non-invasive sensors on the arm, can restore their ability to use their arms and hands so that they can return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. For more information, please visit www.myomo.com.
Home Page: www.myomo.com
MYO Technical Analysis
137 Portland Street
Boston,
MA
02114
United States
Phone:
617 996 9058
Officers
Name | Title |
---|---|
Mr. Paul R. Gudonis | Chairman, Pres & CEO |
Mr. David A. Henry | Chief Financial Officer |
Mr. Micah J. Mitchell | Chief Commercial Officer |
Dr. Harry Kovelman M.D. | Chief Medical Officer |
Exchange: NYSE MKT
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Equipment |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 0.4805 |
Price-to-Sales TTM: | 0.2714 |
IPO Date: | 2017-06-12 |
Fiscal Year End: | December |
Full Time Employees: | 87 |